This post was originally published on this site Transbronchial lung cryobiopsy — a relatively new method of collecting lung tissue for analysis — safely and successfully helps to provide a definitive sarcoidosis diagnosis when the usual and less-invasive diagnostic tools are insufficient, a Portuguese study suggests. The study, “Diagnostic yield and safety of transbronchial cryobiopsy…
About Cancer
Cancer, also called malignancy, is an abnormal growth of cells with the potential to invade or spread to surrounding tissues and structures found within the body. There are more than 100 types of cancer. A few examples include breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and lymphoma. According to the American Cancer Society, 4 out of 10 people will be diagnosed with some form of cancer in their lifetime. Cancer prevalence has given rise to multiple medical specialties focused on symptom management and disease management. Current treatment options depending on the form of cancer include chemotherapy, radiation, blood or bone marrow transfusions, and/or surgery. Lifetime prognosis of cancer mortality is dependent on the type of cancer and is heavily conditional to early detection.
Conditions
Cancer News
Nektar Launches Phase 1 Trial Testing NKTR-255 in Non-Hodgkin’s Lymphoma, Multiple Myeloma
This post was originally published on this site Nektar Therapeutics is launching a first-in-human Phase 1 clinical trial assessing the safety and efficacy of its investigational agent NKTR-255 in people with relapsed or refractory non-Hodgkin’s lymphoma and multiple myeloma. The study (NCT04136756) is recruiting up to 82 patients across multiple U.S. sites and also will…
OTL38 ‘Lights up’ Ovarian Cancer Cells, Helping Surgeons to Remove Them, Phase 2 Study Shows
This post was originally published on this site OTL38, a tumor-specific fluorescent compound that “lights up” ovarian tumor tissue during surgery, helped doctors to detect and remove cancer cells that would otherwise be missed, final results of a Phase 2 study show. The study, “A phase II, multicenter, open-label trial of OTL38 injection for the…
Darzalex Combo Approved in Canada for Newly Diagnosed Myeloma Patients Ineligible for Transplant
This post was originally published on this site Health Canada has approved Darzalex (daratumumab), in combination with standard Revlimid (lenalidomide) and dexamethasone, for people newly diagnosed with multiple myeloma who are not eligible for an autologous stem cell transplant. Under priority review, the approval was based on data from the Phase 3 MAIA trial (NCT02252172), in which…
Nothing but Mammals: How Cancer Affects Sexual Health
This post was originally published on this site This week, I want to dive into a topic that’s not always at the top of the list during one’s oncology appointments. Yet it’s something that most of us do regularly (or at least we’d like to be) and it’s something that — surprise, surprise — cancer…
Tecentriq-Avastin Prolongs Life of Patients with Advanced Liver Cancer in Trial, Roche Reports
This post was originally published on this site A combination of Tecentriq (atezolizumab) and Avastin (bevacizumab) extends overall survival and the time lived without disease progression in people with newly-diagnosed, inoperable hepatocellular carcinoma (HCC), the most common type of liver cancer, compared to standard-of-care treatment with Nexavar (sorafenib), results from the IMbrave150 Phase 3 trial…
Hormone Therapy Has More Long-term Impact on Quality of Life Than Chemo, Study Suggests
This post was originally published on this site Challenging conventional wisdom, new findings suggest that hormone therapy may have a greater impact than chemotherapy on long-term quality of life in women with breast cancer, particularly those who have gone through menopause. The study, “Differential impact of endocrine therapy and chemotherapy on quality of life of…
Zejula Maintenance Increases Time Without Symptoms or Toxicity in Recurrent OC Patients, Study Says
This post was originally published on this site Taking Zejula (niraparib) as a maintenance therapy may increase time without symptoms or toxicities from treatment in women with recurrent ovarian cancer, a new study found. These results suggest that Zejula could increase quality of life in addition to slowing cancer growth. The study, “Niraparib Maintenance Treatment…
Next Up for ‘Moving Mountains for Multiple Myeloma’ — Patagonia
This post was originally published on this site With the goal of encouraging the multiple myeloma community while raising money to advance treatments, Moving Mountains for Multiple Myeloma (MM4MM) is gearing up for its next expedition — Patagonia. The Nov. 9–19 excursion will take participants across the picturesque, but often-rugged, terrain of the region at the southern end of…
Copiktra May Be Treatment Option for Advanced Marginal Zone Lymphoma, Trial Data Show
This post was originally published on this site Copiktra (duvelisib), developed by Verastem Oncology, may be an effective and reasonably safe treatment option for people with marginal zone lymphoma who failed to respond to prior therapies including rituximab, Phase 2 data show. The findings were presented at the Lymphoma & Myeloma 2019 International Congress, held Oct. 23-26 in New…
Pathologist Creates Program Allowing Patients to Face Their Cancer Head-on
This post was originally published on this site Massachusetts pathologist Lija Joseph, MD, has created an innovative program that allows patients, including those with breast cancer, to actually see the cells that make up their malignancies. In doing so, the hope is that patients will gain the understanding, strength, and knowledge that will help them…
Prostate Cancer Patients May Benefit from Routine Tumor Genetic Testing, Study Suggests
This post was originally published on this site Implementation of routine tumor genetic testing may help identify the approximately 30% of men with metastatic castration-resistant prostate cancer (mCRPC) who may significantly benefit from targeted treatment, namely PARP inhibitors, an international study suggests. The results were presented in a poster, titled “Central, prospective detection of homologous…